Determination of drugs used as anti-Parkinson's disease drugs in urine and serum by capillary electrophoresis

Journal of Capillary Electrophoresis and Microchip Technology

Volumn 5, Issue 3-4, 1998, Pages 153-158

  Vargas, Gabriela ^a   Havel, Josef ^a   Babáčková, Lenka ^a   Patočka, Jiří ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

Anti Parkinson's disease drugs; Anticholinergics; Capillary electrophoresis; Determination

Indexed keywords

ADIPHENINE; ANTIPARKINSON AGENT; BENACTYZINE; BETA CYCLODEXTRIN; BUFFER; CARBOXYLIC ACID DERIVATIVE; DIETHYLAMINOETHYL ESTER 1 PHENYLCYCLOPENTANE 1 CARBOXYLATE; DIETHYLAMINOETHYL ESTER TETRAMETHOXYDIPHENYL ACETATE; DIPHEMIN; FENPIVERINIUM BROMIDE; PHENYLACETIC ACID DERIVATIVE; PHOSPHATE; SCOPOLAMINE; SILICON DIOXIDE; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG; DIPHENYLACETIC ACID;

ANALYTIC METHOD; ARTICLE; CAPILLARY ELECTROPHORESIS; CLINICAL MEDICINE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MONITORING; ELECTRIC POTENTIAL; HUMAN; PARKINSON DISEASE; PROCESS OPTIMIZATION; SEPARATION TECHNIQUE; TEMPERATURE MEASUREMENT; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; SOLUTION AND SOLUBILITY; URINE;

ANTIPARKINSON AGENTS; BENACTYZINE; DIPHENYLACETIC ACIDS; ELECTROPHORESIS, CAPILLARY; HUMANS; MOLECULAR STRUCTURE; SCOPOLAMINE; SOLUTIONS; TRIHEXYPHENIDYL;

EID: 0032056596     PISSN: 10795383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tortora GT, Reynolds S. Principles of anatomy and physiology, 7th ed. New York, NY: HarperCollins College Publishers, 1993.
2. Rang HP, Dale MM, Ritter JM. Pharmacology, 3rd ed. New York, NY: Churchill Livingstone, 1995.
3. He H, McKay G, Midha K. Development and application of a specific and sensitive radioimmunoassay for trihexyphenidyl to a pharmacokinetics study in humans. J Pharm Sci 1995; 84:561-7.
4. Desage M, Rousseau-Tsangaris M, Lecompte D. Quantitation of trihexyphenidyl from plasma using a mass selective detector and electron-impact ionization. J Chromatogr 1991; 571:250-6.
5. Stoll L, Fleckenstein P, Riemann D. A simple but highly sensitive radioreceptor assay for the determination of scopolamine and biperiden in human plasma. Res Commun Chem Pathol 1989; 64:59-68.
6. He L, Zhang G, Tong Y. Determination of hyoscyamine, scopolamine, anisodamine and anisodine in solanaceous plants by high performance liquid chromatography. Jap J Pharm 1990; 44:162-9.
7. Mandal S, Naqvi A, Thakur R. Simultaneous determination of atropine and scopolamine in plants by mixed-column high performance liquid chromatography. Phytochem Anal 1991; 2:208-10.
8. Oshima T, Sagara K, Tong Y. Application of ion-pair high-performance liquid chromatography for analysis of hyoscyamine and scopolamine in solanaceous crude drugs. Chem Pharm Bull 1989; 37:2456-8.
9. Fliniaux MA, Manceau F, Jacquin-Dubreuil A. Simultaneous analysis of L-hyoscyamine, 1-scopolamine and dl-tropic acid in plant material by reversed-phase high-performance liquid chromatography. J Chromatogr 1993; 644:193-9.
10. Papadoyannis I, Zotou A, Samanidou V. Solid-phase extraction and RP-HPLC analysis of atropine sulphate and scopolamine-N-butylbromide in pharmaceutical preparations and biological fluids. Instrumen Sci Technol 1994; 22:83-8.
11. Oertel R, Richter K, Kirch W. Determination of scopolamine in human serum by gas chromatography-ion trap tandem mass spectrometry. J Chromatogr B 1996; 682:259-64.
12. Monforte-Gonzalez M, Ayora-Talavera T, Maldonado-Mendoza IE. Quantitative analysis of serpentine and ajmalicine in plant tissues of Catharonthus roseus and hyoscyamine and scopolamine in root tissues of Datura stamonium by thin layer chromatography-densitometry. Phytochem Anal 1992; 3:117-21.
13. Whelpton R, Hurst PR, Metcalfe RF. Liquid chromatographic determination of hyoscyamine (scopolamine) in urine using solid phase extraction. Biomed Chromatogr 1992; 6:198-204.
14. Babáčková, L, Vargas G, Havel J, Patočka J. Central active cholinolytics and their estimation by capillary zone electrophoresis. ASA Newsletters 1997, 2:16-8.
15. Craig DH, Rosen P. Abuse of antiparkinsonian drugs. Ann Emerg Med 1981; 10:98-100.
16. Crawshow JA, Mullen PE. A study of benzhexol abuse. Br J Psychiat 1984; 145:300-3.
17. Fisch RZ. Trihexyphenidyl abuse. Therapeutic implications for negative symptoms of schizophrenia. Acta Psych Scand 1987; 75:91-4.
18. Land W, Pinsky D, Salzman C. Abuse and misuse of anticholinergic medications. Hosp Commun Psych 1991; 42:580-1.
19. Marken PA, Stoner SC, Bunker MT. Anticholinergic drug abuse and misuse. Epidemiology and therapeutic implications. CNS Drugs 1996; 5:190-9